MannKind menetapkan target pendapatan Furoscix 2026 sebesar $110 juta - $120 juta seiring pengiriman ReadyFlow dalam beberapa minggu (NASDAQ:MNKD)
· seekingalpha.com
Rekapitulasi laporan laba Q2 2026 MannKind (MNKD): penyerapan Afrezza pediatrik, jadwal peluncuran Furoscix ReadyFlow, bauran pendapatan, kas, dan risiko—baca sekarang.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...